西班牙在伊朗战争期间永久撤回驻以色列大使

(SeaPRwire) -   西班牙于周二永久撤回其驻以色列大使,原因是反对美以对,伊朗的打击行动,这加剧了两国之间本已紧张的外交裂痕。西班牙政府在其官方公报中正式终止了大使职位,并,,表示其驻特拉维夫大使馆将无限期由临时代办领导。去年9,月,以色列谴责西班牙禁止向以色列运送武器的飞机和船只使用西班牙港口或领空的决定后,马德里,,召回了其大使。当时,以色列外交部长吉迪恩·萨阿(Gideon Sa’ar)称这一举措是,反犹太主义的。周三,当一名记者询问西班牙是否,总体上与美国合作时,唐纳德·特朗普总统回答说:“不,他们没有。,我认为他们根本没有合作。”“西班牙,我认为他们表现得非常糟糕,”总统说。“非常糟糕。一点都不好。,,我们可能会切断与西班牙的贸易。”“我不知道西班牙在做什么,”特朗普继续说。“他们对北约非常不友好。他们得到保护,却不愿支付公平份额。而且他们多年来一直如此。”特朗普补充说,西班牙人民“非常棒”,而领导层“不太好”。南卡罗来纳州共和党参议员林赛·格雷厄姆(Lindsey Graham)周三批评西班牙永久召回驻以色列大使的决定“让我难以接受”。“西班牙是北约成员国,,而美国和以色列正在联合行动对抗伊朗政权,该政权公开呼吁摧毁犹太国家,攻击西方,并试图按照自己的形象净化,,伊斯兰教,”格雷厄姆在X上写道。“伊朗的宗教纳粹政权是问题所在,而不是犹太国家,”这位参议员继续说。“我希望西班牙的行动不会,,鼓励伊朗那个虐待本国人民的专制、狂热政权继续存在。”自以色列针对2023年10月7,日哈马斯恐怖袭击在加沙发起军事行动以来,西班牙和以色列,,的关系急剧恶化。,去年5月,西班牙承认,,巴勒斯坦国后,以色列也降低了其在西班牙的外交存在,将其驻马德里大使馆交由临时代办管理。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

加拿大总理特鲁多面临压力,要求其就犹太教堂遭枪击事件采取行动

(SeaPRwire) -   上周末,多伦多的两座犹太教堂遭到枪击。几天前,另一座犹太教堂在犹太节日普珥节期间遭到大约二十发子弹的袭击。尽管这三起袭击未造成人员伤亡,但犹太社区的许多人要求总理马克·卡尔尼采取具体行动,而不仅仅是此类反犹事件后通常出现的安慰之词。卡尔尼在X平台上表示,"这些反犹主义和犯罪行为侵犯了加拿大犹太男女在完全安全的环境中生活和祈祷的权利",并且"是对所有加拿大人生活方式的严重攻击。"在第一座犹太教堂遇袭后,以色列国家安全委员会警告海外以色列人要"保持警惕并遵守安全预防措施"。他们的建议包括,以色列人"在公共场所隐藏犹太人和以色列人的标识物","在与以色列或犹太教相关的区域"注意周围环境,以及"避免前往被认定为犹太或以色列的地点。"以色列总统艾萨克·赫尔佐格在X平台上表示,"全世界的目光都聚焦在加拿大:是时候制止自10月7日以来爆发的这波前所未有的反犹仇恨浪潮了。"与许多西方国家一样,自2023年10月7日哈马斯在以色列发动恐怖袭击以来,加拿大的年度反犹事件显著增加。加拿大圣约之子会人权联盟发现,2024年加拿大发生了6,219起反犹事件。这相当于平均每天17起,是2022年计算的每天8起的两倍多。虽然2025年的数据尚未公布,但加拿大公共安全部指出,从2025年4月到6月,"在针对宗教的仇恨犯罪中……大多数是针对犹太社区的(69%)。"保守党议员罗曼·巴伯表示,加拿大总理马克·卡尔尼和其他加拿大自由党政客的行为一直在"为加拿大的反犹仇恨火上浇油。"巴伯进一步批评卡尔尼说:"当总理在竞选活动中说他加沙正在发生种族灭绝时,他就是在参与反犹仇恨。"巴伯指的是2025年4月的一次活动,当时一名抗议者在喧闹的人群中高喊"加沙正在发生种族灭绝"。卡尔尼回应说:"我知道,所以我们有武器禁运。"卡尔尼后来表示,他没有听到抗议者使用"种族灭绝"这个词。巴伯指出,"当总理承认巴勒斯坦国时,他奖励了哈马斯的暴行,而且他是在犹太新年(Rosh Hashanah)前夕这样做的。"在犹太节日前一天发布的声明中,卡尔尼声称,承认"由巴勒斯坦权力机构领导的巴勒斯坦国,是为了赋予那些寻求和平共处和终结哈马斯的人权力",并且"绝不意味着使恐怖主义合法化,也不是对其的任何奖励。"他还声称,承认巴勒斯坦国"绝不损害加拿大对以色列国、其人民及其安全的坚定支持。"监督组织StopAntisemitism告诉 Digital,"每一天,我们都在看到痛苦的提醒,即反犹主义仍然是一个真实而危险的威胁。旨在恐吓或压制我们社区的暴力行为不会得逞。响亮而自豪的犹太人不会允许仇恨或恐惧阻碍我们的犹太生活方式或我们在世界上的存在。无论是在加拿大、美国、欧洲,当然也不会在以色列。"StopAntisemitism呼吁将肇事者"依法予以最严厉的惩处,以伸张正义并明确起到威慑作用。"本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

美国驻伊拉克外交设施遭无人机袭击

(SeaPRwire) -   据《华盛顿邮报》报道,周二,亲伊朗民兵组织发动的疑似报复性无人机袭击击中了巴格达一处重要的美国外交设施。该报称,袭击目标为巴格达外交支持中心,目前暂无人员伤亡报告。共有6架无人机被射向该建筑群,其中5架被击落。《华盛顿邮报》援引一名安全官员和美国国务院的警报报道称,一架无人机击中了一座警卫塔附近,该设施内人员被要求“隐蔽躲避”。警报称:“追责工作正在进行中。”伊拉克国防部在X平台发文谴责了针对烈士穆罕默德·阿拉空军基地和烈士阿里·法拉空军基地的无人机及导弹袭击,但未直接提及美国设施遇袭事件或伊朗。该政府账号写道:“针对这些罪恶袭击,国防部特此澄清并确认以下事实:这些空军基地完全属于伊拉克主权范围,完全受国家和法律管辖,不存在任何名义下的外国军队部署。”该安全官员向《华盛顿邮报》表示,此次袭击可能由与“伊拉克伊斯兰抵抗组织”有关联的民兵组织发动。“伊拉克伊斯兰抵抗组织”是一个由与伊朗结盟的什叶派武装派别组成的松散 umbrella 团体,这些派别曾宣称对该地区针对美军的袭击负责。在“Operation Epic Fury”行动启动之初,美国国务院就敦促美国人立即离开中东地区十多个国家,警告称随着伊朗局势升级,存在“严重安全风险”。美国国务院领事事务助理国务卿莫拉·南达尔(Mora Namdar)3月2日表示,美国公民应离开巴林、埃及、伊朗、伊拉克、以色列、约旦河西岸和加沙地带、约旦、科威特、黎巴嫩、阿曼、卡塔尔、沙特阿拉伯、叙利亚、阿拉伯联合酋长国和也门。国务院表示,需要帮助安排商业途径离境的美国人可随时联系国务院:从国外拨打+1-202-501-4444,从美国和加拿大拨打+1-888-407-4747。官员警告称,该地区局势仍不稳定,随着与冲突相关的战斗持续,安全形势可能迅速变化。在伊朗对美军和以色列发动报复性袭击之初,至少有9个美国驻外机构(包括驻巴林、伊朗、科威特、阿拉伯联合酋长国、沙特阿拉伯、伊拉克、约旦、卡塔尔和以色列的机构)多次发布就地避难指令或通知。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

Yuexiu REIT Maintains Operational Resilience, Revenue Exceeds RMB1.8 Billion in 2025

HONG KONG, Mar 11, 2026 - (ACN Newswire via SeaPRwire.com) – Yuexiu Real Estate Investment Trust ("Yuexiu REIT", together with Yuexiu REIT Asset Management Limited, collectively known as the “REIT”; stock code: 405) announced its annual results for the year ended 31 December 2025.Yuexiu REIT Management Team: Chairman and Non-Executive Director Mr. JIANG Guoxiong (center), Executive Director and Chief Executive Officer Ms. OU Haijing (left), and Chief Financial Officer Mr. KWAN Chi Fai (right)2025 Annual Results Highlights:                                                    - Overall operation remained resilient, with total revenue of RMB1,856 million (2024: RMB2,032 million).- The average financing cost was 3.61%, a three-year low; the average interest payment rate was 3.77%, representing a year-on-year decrease of 76 basis points. Excluding exchange loss, the financing expenses decreased by approximately RMB152 million year-on-year.- As at 31 December 2025, the overall occupancy rate of the properties was 82.1% (2024: 84.5%).- Optimised the asset portfolio by disposing of a 50% interest in Yuexiu Financial Tower in Q4 2025, realising cash proceeds of approximately RMB5.3 billion to enhance financial flexibility. Yuexiu REIT maintained its "investment-grade" rating from both Standard & Poor's and Fitch, with the outlook upgraded to "stable".- The final distribution to the Unitholders for the period will be approximately RMB0.0189, equivalent to HK$0.0214. Distribution per Unit for the year will be approximately RMB0.0522, equivalent to HK$0.0580. Distribution yield is 6.74% per Unit for the year.- To maintain the REIT’s financial flexibility, the distribution ratio for the period from 1 July 2025 to 31 December 2025 has been adjusted to 90%, resulting in an overall full-year distribution ratio of approximately 96%.Guangzhou International Finance Center (GZIFC):- Operating revenue of the GZIFC complex was RMB984 million, accounting for 53.0% of the REIT’s total revenue.- The office building of GZIFC introduced two Fortune Global 500 companies; the occupancy rate was 80.9%.- GZIFC Shopping Mall introduced China Duty Free Group (CDFG), the first and currently the only downtown duty-free store in Guangzhou, achieving a renewal rate of 89% for the year, and an occupancy rate of 95.5% at the end of the period.- Four Seasons Hotel Guangzhou's average room rate increased by 5.8% year-on-year. Ascott Serviced Apartments GZIFC achieved an average occupancy rate of 91.5%, up 1 percentage point year-on-year, with revenue reaching a record high for the period.Proactive Management of Financing Risk and Effective Stabilisation of Financing Cost- With regard to the short-term loan of RMB530 million, the 5-year syndicated loan of HK$2.1 billion, and the remaining HK$2.1 billion of the 3-year syndicated loan of HK$3.8 billion, all due in 2025, the Manager in 2025 renewed the short-term loan of RMB530 million, obtained offshore loan of RMB1.7 billion, issued dim sum bonds of RMB1 billion, and obtained an offshore syndicated loan package equivalent to HK$2.1 billion (a sustainability-linked loan), for the refinancing of the maturing loans so as to ensure effective monitor on the liquidity risk.- A total of approximately RMB4.68 billion in loans were obtained in 2025 to partially refinance offshore HKD floating rate loans, taking advantage of the relatively low-cost of RMB financing to proactively adjust the financing structure. At the end of 2025, the financing interest rate exposure of Yuexiu REIT was approximately 10%, narrowed by 16 percentage points from 26% at the beginning of the year; the average financing cost was 3.61%, a three-year low, representing a decrease of 55 basis points from 4.16% at the beginning of the year; the average interest payment rate for the full year of 2025 was 3.77%, representing a year-on-year decrease of 76 basis points. Excluding the exchange loss, the finance expenses were approximately RMB773 million, representing a year-on-year decrease of approximately RMB152 million.- As at the end of 2025, Yuexiu REIT had RMB financing of approximately RMB15.47 billion, accounting for 76% of total financing (2024: RMB financing of approximately RMB12.33 billion, accounting for 60% of total financing).Mr. JIANG Guoxiong, Chairman and Non-Executive Director of Yuexiu REIT, said, "2025 marked the 20th anniversary of Yuexiu REIT's listing. The Manager consolidated its competitive advantages by taking strategic actions to secure market share, prioritised occupancy rates, strengthened risk control to stabilise lease renewals, enhanced product competitiveness to meet market demand and invested in capital renovation projects to ensure asset value preservation and appreciation. These efforts stabilised the fundamentals of operations in a challenging market, providing solid support for the full-year revenue. Concurrently, we optimised the asset portfolio by appropriately reducing the proportion of office buildings, and proactively captured favourable financing opportunities, successfully issuing the first-ever Panda Bonds by a listed REIT globally as well as the REIT’s inaugural green bond. Financing costs for the year reached a three-year low, effectively underpinning the overall distribution level. The successful execution of a series of pioneering capital operations fully demonstrated the Manager’s strategic commitment to driving the high-quality development of Yuexiu REIT. This underscored its resolute determination in creating sustainable and long-term value for Unitholders.”Guangzhou International Finance Center (GZIFC)During the year, GZIFC recorded a newly contracted area of 15,702 sq.m. The newly launched 7,403 sq.m. of furnished units recorded an absorption cycle of about 36 days, with an absorption rate close to 72%. Quality tenants introduced include two Fortune Global 500 companies, a Fortune China 500 company, a leading global shipping giant, and a renowned Internet-based culture, sports and entertainment company. In addition, the project recorded a renewal area of 34,294 sq.m. and a renewal rate of 86%, retaining quality tenants including six Fortune Global 500 companies and a foreign consulate. GZIFC was selected as one of the Top 30 companies in the “Performance Index - 2025 Commercial Property Operation Performance)” by Guandian.GZIFC Shopping Mall renewed lease with its anchor tenant, Guangzhou Friendship Store, and introduced China Duty Free Group (CDFG) to set up a store, which is the first and currently the only downtown duty-free store in Guangzhou. In addition, GZIFC Shopping Mall launched the light meal and beverage area on the basement floor, coupled with the brand revitalisation of the dining tenants on the fourth and fifth floors by introducing seven “first stores”. Membership operations achieved remarkable results, with the share of member sales doubling to 16%. The project actively created digitalised consumption scenarios and made full use of mainstream platforms to attract customer flow through multiple channels. Specifically, the “Italian Culture Season” themed event was successfully held in collaboration with hotels, theaters, museums and consulates, effectively boosting customer flow and sales. Newly contracted area and renewal area totaled 35,573 sq.m., with a renewal rate of 89%. The occupancy rate was 95.5%.Four Seasons Hotel Guangzhou launched the first batch of renovated rooms during the year. The average room rate was RMB2,260, representing a year-on-year increase of 5.8%. The average occupancy rate was 77.7%. The revenue per available room (RevPAR) was RMB1,756, representing a year-on-year increase of 0.9%. The RevPAR competitive index was 110.0, maintaining a relatively leading market position among luxury hotel competitors. Ascott Serviced Apartments GZIFC recorded an average occupancy rate of 91.5% during the year, representing a year-on-year increase of 1 percentage point. The average room rate was RMB1,137, representing a year-on-year increase of 1.6%. The RevPAR was RMB1,040, representing a year-on-year growth of 2.7%. The RevPAR competitive index reached 146.9, remaining at a high level among high-end apartment competitors. The Apartments achieved a record high in operating revenue for the same period and ranked first in operating revenue among Ascott China properties for ten consecutive years since 2016.Yuexiu Financial TowerThe Manager disposed of 50% interest in Yuexiu Financial Tower in Q4 2025. Following completion of the disposal, Yuexiu Financial Tower became a Qualified Minority-owned Property of the REIT. The occupancy rate was 77.9% at the end of the period.White Horse BuildingWhite Horse Building introduced high-quality customers from core industrial clusters in Guangzhou, Shenzhen and Dongguan and recorded a newly contracted area of 5,808 sq.m. for the year, with full occupancy on the 1st floor for the first time in the past five years and a six-year record high set by the 2nd floor’s occupancy rate. During the year, it organised 22 original brands to showcase their products at professional exhibitions such as the Fashion World Tokyo, and the China International Fashion Fair; held the “White Horse Fashion Journey: Border Trade Supply Chain Matching Conference”, and established the “Guangdong-Xinjiang Fashion Industry Chain Supply and Procurement Cooperation Alliance” with ten wholesale markets in Urumqi, Xinjiang. During the year, it welcomed a total of 517 procurement delegations, along with nearly 13,000 purchaser visits, including 19 foreign delegations from France, Vietnam and other countries, and facilitated procurement deals worth RMB320 million. The occupancy rate was 96.0% at the end of the period.Fortune PlazaDuring the year, the project recorded a newly contracted area of 6,334 sq.m., and introduced certain quality tenants including several subsidiaries of a Fortune Global 500 integrated financial group, two Fortune Global 500 companies and the Guangzhou branch of two global leading companies. The project recorded a renewal area of 8,662 sq.m. and a renewal rate of 84.0%, retained quality tenants including three Fortune Global 500 companies and the Guangzhou branch of a national commercial bank. Upgraded product standards accelerated the absorption of vacant units, with an absorption rate of 93% for furnished units. The occupancy rate was 93.4% at the end of the period, representing a year-on-year increase of 1 percentage point, and a strong rebound of 5.4 percentage points from the interim period.City Development PlazaDuring the Reporting Year, the project recorded a newly contracted area of 9,279 sq.m. and introduced a beauty technology company and a pharmaceutical supply chain service company to enhance the ambience of healthcare business in the building. The project recorded a renewal area of 5,011 sq.m. and a renewal rate of 77%, retained tenants including a Fortune Global 500 company and a globally-renowned Contract Research Organisation (CRO). The occupancy rate was 90.6% at the end of the period.Victory PlazaVictory Plazq’s anchor tenant, Uniqlo, continued to play a flagship role, recording a 7.0% year-on-year sales growth for the year and maintaining its position as the top-selling store nationwide. The project successfully introduced the sports brand “Super Anta” to set up the largest store in the Guangzhou-Foshan region and “Crab Mang Mang”, the first store nationwide of Guizhou spicy crab business, achieved the diversification of its food and beverage brand portfolio. By connecting internal and external resources to hold fifteen major events, the mall achieved a year-on-year increase of 2.0% in its annual sales. During the year, newly contracted area and renewal area totaled 5,579 sq.m., with a renewal rate of 84%. The occupancy rate was 94.0% at the end of the period.Shanghai Yue Xiu TowerDuring the year, Shanghai Yue Xiu Tower recorded a renewal area of 6,430 sq.m., with a renewal rate of 43%, while securing a newly contracted area of 8,070 sq.m., efficiently making up for the prematurely vacated units. During the year, the project continued to increase the supply of small-area furnished units to meet market demand, formulated differentiated pricing strategies, and successfully held a channel recruitment conference, which attracted more than one hundred real estate agencies. By investing in various capital nature renovations, the project enhanced both energy efficiency and service standards. The occupancy rate was 83.1% at the end of the period.Wuhan PropertiesDuring the year, Wuhan Yuexiu Fortune Centre recorded a newly contracted area of 26,837 sq.m., and introduced quality tenants including two Fortune Global 500 state-owned enterprises, and two Fortune Global 500 foreign enterprises. In addition, it recorded a renewal area of 20,617 sq.m. and a renewal rate of 76.0%, hitting a new high in the past three years, and retained quality tenants, including seven Fortune Global 500 enterprises and a Fortune China 500 company. Approximately 21,000 sq. m. of renovated units were supplied throughout the year, with an absorption rate approaching 98%. The occupancy rate was 62.1% at the end of the period, representing a year-on-year increase of 1 percentage point.Wuhan Starry Victoria Shopping Centre revitalised several popular dining and fitness brands, aiming to attract more family and young customer groups. The project deeply tapped into the consumption potentials of “night economy” and “scene experience” by leveraging the unique venue feature of “Joy Garden”, launching themed activities such as “Riverside Starry Night ”, thus achieving customer flow substantially in line with last year, while the shopping mall recorded a year-on-year increase of 0.5% in annual sales. During the year, newly contracted area and renewal area totaled 9,827 sq.m., with a renewal rate of 48.0%. The occupancy rate was 87.4% at the end of the period, representing a rebound of 5.0 percentage points from the interim period.Hangzhou VictoryDuring the year, the project recorded a newly contracted area of 7,890 sq.m. and introduced a tenant to take up an entire floor. In addition, it recorded a renewal area of 8,836 sq.m. and a renewal rate of 54%, retained quality tenants including two Fortune Global 500 companies and the Zhejiang branch of a state-owned enterprise in Shanxi Province. The occupancy rate was 84.5% at the end of the period.Integrating ESG into Business and Promoting Sustainable DevelopmentAdhering to a long-term perspective, the Manager systematically advanced ESG initiatives. On the occasion of publicly disclosing Yuexiu REIT’s sustainability practices for the tenth consecutive year, the Manager officially renamed the “Environmental, Social and Governance Report” to the “Sustainability Report”, further promoting the deep integration of Yuexiu REIT’s strategy into sustainable development and reinforcing their synchronized progress. During the year, Yuexiu REIT received the highest Green Five Star rating and the title of “Global Sector Leader” for the first time from the Global Real Estate Sustainability Benchmark (GRESB) and once again secured A-rating (highest level) for public disclosure, highlighting its outstanding capabilities in the field of sustainable development.ProspectsIn the coming year, the Manager will maintain a prudent and optimistic attitude, adapt proactively to changes and strengthen risk managemen to generate stable return for the Unitholders. In terms of asset management, the Manager will dynamically implement proactive, prudent and flexible leasing and operating strategies in response to economic development trends and competitive dynamics, diligently explore new growth drivers, and keenly seize potential opportunities to enhance the market competitiveness of asset portfolio. In terms of financing management, the Manager will continue to review and make reasonable adjustments to its financing structure, and introduce low-cost RMB financing through various financing channels to offset interest rate risks. In respect of renovation projects, the Manager will carry out the phased renovations of Four Seasons Hotel Guangzhou in an orderly manner to support the long-term preservation and appreciation of property value.About Yuexiu Real Estate Investment TrustYuexiu Real Estate Investment Trust ("Yuexiu REIT") was listed on the Hong Kong Stock Exchange of Hong Kong Limited on 21 December 2005 and is the first listed real estate investment trust only investing in properties in the People's Republic of China (the "PRC") in the world. As of 31 December 2025, Yuexiu REIT’s portfolio of properties consisted of ten properties (including one Qualified Minority-owned Property), namely, White Horse Building, Fortune Plaza, City Development Plaza, Victory Plaza, Guangzhou International Finance Centre (“GZIFC”), Yuexiu Financial Tower (a Qualified Minority-owned Property with a 49.495% beneficial interest) located in Guangzhou; Yue Xiu Tower located in Shanghai; Wuhan Yuexiu Fortune Centre, and Starry Victoria Shopping Centre located in Wuhan; Victory Business Centre located in Hangzhou; and Yue Xiu Building located in Hong Kong. The total gross floor area of the properties (excluding Yuexiu Financial Tower) was approximately 974,000 sq.m. All properties are located in the central business district of Guangzhou, Shanghai, Wuhan, Hangzhou and Hong Kong respectively. The categories of the properties include Grade-A offices, commercial complexes, retail business, hotel, serviced apartments and professional clothing market etc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

云顶新耀维适平(R)中国大陆首张处方落地 填补中重度溃疡性结肠炎治疗空白

香港, 2026年3月11日 - (亚太商讯 via SeaPRwire.com) - 云顶新耀(01952.HK)宣布,旗下自身免疫性疾病领域核心产品维适平(R)(精氨酸艾曲莫德片,VELSIPITY(R))中国大陆首张处方在3月9日于中山大学附属第一医院开出,标志着这款创新疗法正式进入中国临床应用阶段。据悉,在中国大陆首方开具当天,维适平(R)已在广州、上海、杭州、西安、重庆、北京和南京7个核心城市的8家三甲医院同步开出处方,实现上市首日即覆盖全国重点区域患者,并通过互联网医院渠道进一步扩大患者覆盖范围。目前,该药物已在中山大学附属第一医院、浙江大学医学院附属邵逸夫医院、中国人民解放军空军军医大学第一附属医院、重庆市人民医院、中国医学科学院北京协和医院等多家核心医疗机构惠及患者。值得关注的是,维适平(R)于今年2月获得国家药监局批准上市,仅一个月便实现中国大陆首方落地,推进速度明显快于行业平均水平。业内认为,这不仅反映出该产品较高的临床需求,也体现了云顶新耀在创新药商业化方面的执行效率。从疾病负担来看,炎症性肠病(IBD)已被认为是全球增长最快的消化系统疾病之一。IBD主要包括溃疡性结肠炎(UC)和克罗恩病(CD)。近年来,随着饮食结构变化、生活方式改变以及诊断水平提升,中国患者数量持续增加。多家行业研究机构预计,到2030年前后,中国IBD治疗市场规模有望突破百亿元人民币,其中新型小分子创新药将成为主要增长动力之一。从临床需求来看,溃疡性结肠炎是一种病因尚不明确、易复发的慢性肠道炎症性疾病,临床表现为黏液血便、腹痛、腹泻、里急后重等症状,严重影响患者长期生活质量。近年来,中国该病发病率和患病率持续上升且呈年轻化趋势,预计患者人数将由2025年的约98万增长至2031年的约150万。目前该病仍无法治愈,患者需长期用药维持疾病控制,而传统疗法疗效有限、生物制剂存在“疗效天花板”,临床亟需能实现更稳定、持久疾病控制的创新方案。维适平(R)作为每日口服一次的新一代高选择性S1P受体调节剂,具备最佳药物(best-in-disease)潜质,已获得美国胃肠病学协会(AGA)临床实践指南与美国胃肠病学会(ACG)临床指南强烈推荐,作为中重度溃疡性结肠炎的一线用药。多项全球临床研究证实其疗效与安全性良好,尤其在快速起效、实现无激素缓解及深度黏膜愈合方面具有明显临床优势。在迄今最大规模的中重度UC患者亚洲多中心III期临床研究(ENLIGHT UC)中,维适平(R)维持治疗40周,临床缓解率达48.1%,深度黏膜愈合率达51.9%,内镜正常化率达45.5%。数据显示,维适平(R)可实现强效深度黏膜愈合,从而改善疾病长期预后,并有助于降低复发及癌变风险。全球Ⅲ期ELEVATE研究的一项开放标签扩展研究数据证实,持续维适平(R)治疗3年,在观察病例中,86.8%患者实现临床应答,临床缓解率和黏膜愈合率均维持在约60%水平。全球临床研究随访5年的数据进一步表明其稳定且良好的安全性特征,整体耐受性良好。中华医学会消化病学分会前任主任委员、中山大学附属第一医院消化内科学术带头人陈旻湖教授指出,维适平(R)此次首张处方的开具,有望进一步优化溃疡性结肠炎的临床管理路径,推动疾病治疗向更高水平发展,实现黏膜愈合的治疗目标,惠及更多患者。云顶新耀首席执行官罗永庆表示,黏膜愈合是当前溃疡性结肠炎的治疗目标,尽早实现可大幅降低患者疾病复发率、住院率、手术率和癌变风险。维适平(R)可从源头控制肠道炎症,促进黏膜愈合,填补了中重度溃疡性结肠炎治疗领域的空白。作为一款治疗溃疡性结肠炎的创新一线治疗药物,维适平(R)兼具“疗效、安全性及方便性”三重优势,为患者提供长期疾病控制与生活质量改善的保障。此外,该药物于2024年和2025年被纳入粤港澳大湾区内地9市临床急需进口港澳药品医疗器械目录,在大湾区率先实现临床应用,且在真实诊疗场景中的表现与临床研究疗效、安全性一致。商业化层面,云顶新耀已通过肾科核心产品耐赋康(R)验证了成熟可复制的商业化能力。作为全球首个且目前唯一在中、美、欧获得完全批准的IgA肾病对因治疗药物,耐赋康(R)在2025年前三季度销售额突破10亿元,创造了非肿瘤产品的历史,成为过去十年慢病药进医保销售最好的产品。该产品的成功,验证了以“科学及商业洞察驱动的准入、医学、市场、销售一体化协同(A2MS)”为核心的创新药商业化运营平台,也为后续产品的市场拓展提供了可复用的体系与经验。此次维适平(R)首方快速落地,进一步印证了该平台的高效性,依托耐赋康(R)的渠道网络与市场准入经验,其有望复刻增长路径。从市场格局来看,长期以来中国溃疡性结肠炎治疗市场以传统免疫抑制剂和注射型生物制剂为主,这些方案存在口服便利性不足、长期安全性风险等问题。维适平(R)凭借差异化优势,被业界认为有望填补这一需求缺口,行业普遍预期其销售峰值可达50亿元,成为驱动云顶新耀业绩增长的重要引擎。云顶新耀表示,将构建多渠道准入体系,提供多元化患者援助项目和创新支付方案,并全力推动维适平(R)纳入国家医保目录,以提升药物的可及性和可负担性。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Everest Medicines Announces Commercial Launch and First Prescription for VELSIPITY(R) in Mainland China, Addressing Unmet Need in Moderately to Severely Active Ulcerative Colitis

HONG KONG, March 11, 2026 - (ACN Newswire via SeaPRwire.com) – March 9, Everest Medicines (1952.HK) announced the commercial launch of VELSIPITY(R) (etrasimod arginine tablets) in Mainland China, highlighted by the issuance of the first prescription at The First Affiliated Hospital of Sun Yat-sen University, marking a milestone in patient access in the region. According to reports, on the day the first prescription was issued in mainland China, VELSIPITY(R) was simultaneously prescribed in eight tertiary hospitals across seven key cities—Guangzhou, Shanghai, Hangzhou, Xi’an, Chongqing, Beijing, and Nanjing—achieving immediate coverage of patients in major regions nationwide on its launch day. The drug has also expanded patient access through internet hospital platforms. To date, patients at leading medical institutions, including the First Affiliated Hospital of Sun Yat-sen University, Sir Run Run Shaw Hospital, the First Affiliated Hospital of the Air Force Medical University of the People's Liberation Army, Chongqing People’s Hospital, and Peking Union Medical College Hospital, have already benefited from the therapy.Notably, VELSIPITY(R) was approved for marketing by China’s National Medical Products Administration (NMPA) in February this year. The first prescription in mainland China was issued just one month later, marking a rollout significantly faster than the industry average. Industry observers believe this not only reflects the strong clinical demand for the product but also demonstrates Everest Medicines’ execution capabilities in the commercialization of innovative drugs.From a disease burden perspective, inflammatory bowel disease (IBD) is considered one of the fastest-growing gastrointestinal diseases worldwide. IBD mainly includes ulcerative colitis (UC) and Crohn’s disease (CD). In recent years, the number of patients in China has continued to increase, driven by changes in dietary patterns, shifts in lifestyle, and improvements in diagnostic capabilities. Several industry research institutions predict that China’s IBD treatment market could exceed RMB 10 billion by around 2030, with novel small-molecule innovative drugs expected to become one of the key drivers of market growth.From a clinical perspective, ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease characterized by symptoms such as mucus and blood in the stool, abdominal pain, diarrhea, and rectal tenesmus, which can significantly affect patients’ quality of life. In China, both the incidence and prevalence of UC are increasing, with a clear trend toward younger patients. The patient population is projected to grow from approximately 0.98 million in 2025 to about 1.50 million by 2031. As the disease remains incurable, patients require long-term management to maintain disease control.VELSIPITY(R) is a next-generation, highly selective S1P receptor modulator with best-in-disease potential and strong first-line treatment recommendations for moderately to severely active ulcerative colitis (UC) in both the American Gastroenterological Association (AGA) Clinical Practice Guideline and the American College of Gastroenterology (ACG) Clinical Guideline Update.Results from multiple global clinical studies have demonstrated that VELSIPITY(R) delivers meaningful clinical benefits, including rapid onset of action, long-lasting clinical remission, steroid-free remission, and deep mucosal healing, with a favorable safety profile. In the ENLIGHT UC study, the largest Asian multicenter Phase 3 clinical study, the clinical remission rate at week 40 of the maintenance period reached 48.1%, and the deep mucosal healing rate reached 51.9%, with an endoscopic mucosal normalization rate of 45.5%. These findings demonstrate VELSIPITY(R)'s potential to improve long-term disease outcomes and reduce the risk of relapse and disease progression.Results from the ELEVATE UC open-label extension demonstrate continuous treatment with VELSIPITY(R) for up to 3 years resulted in 86.8% of patients achieving a clinical response among the observed cases, with both clinical remission and mucosal healing rates maintained at approximately 60%. Safety data extending up to five years from the global clinical program further confirm that VELSIPITY(R) is well tolerated and maintains a favorable and stable safety profile.Prof. Chen Minhu, Academic Leader of the Department of Gastroenterology at The First Affiliated Hospital of Sun Yat-sen University, noted that with the first prescription now issued, VELSIPITY(R) is being incorporated into routine clinical practice, providing physicians with an innovative treatment option for patients living with UC who continue to face ongoing disease challenges.“Early achievement of mucosal healing is recognized as a key treatment goal, as it can significantly reduce rates of disease relapse, hospitalization, surgery, and the risk of progression to colorectal cancer. VELSIPITY(R) addresses this need by targeting intestinal inflammation at its source and promoting mucosal healing, while offering a favorable profile of efficacy and safety, along with the convenience of an oral, once-daily regimen, supporting sustained disease management and improving patients' quality of life,” said Mr. Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines.In 2024 and 2025, VELSIPITY(R) was included in the Catalogues of Guangdong Province on Drugs and Medical Devices from Hong Kong and Macao in Urgent Clinical Use in Nine Mainland Municipalities of the Guangdong-Hong Kong-Macao Greater Bay Area, making it available at designated hospitals across the region. Real-world data have shown that the efficacy and safety of VELSIPITY(R) are consistent with those observed in clinical trials.From a commercialization perspective, Everest Medicines has already demonstrated a mature and replicable capabilities through its core nephrology product NEFECON(R). As the world’s first and currently the only etiological treatment for IgA nephropathy (IgAN) to receive full approvals in China, the United States, and Europe, Nefecon(R) generated more than RMB 1 billion in sales in the first three quarters of 2025. The product has set a new benchmark for non-oncology therapies and has become one of the best-performing chronic disease drugs added to China’s national reimbursement list over the past decade.This achievement has validated the company’s platform for the commercialization of innovative medicines, centered on the integrated coordination of access, medical, marketing, and sales (A2MS) driven by scientific and commercial insights. It has also provided replicable systems and experience for the market expansion of future products. The rapid issuance of the first prescription for VELSIPITY(R) further demonstrates the efficiency of this platform. Leveraging the channel network and market access experience built through Nefecon(R), the product is expected to replicate a similar growth trajectory.From a market landscape perspective, China’s UC treatment market has long been dominated by traditional immunosuppressants and injectable biologics. However, these therapies present certain limitations, including lack of oral convenience and potential long-term safety risks. With its differentiated advantages, VELSIPITY(R) is widely viewed by the industry as having the potential to address this unmet need. Market expectations suggest that the drug could reach peak sales of RMB 5 billion, becoming a key driver of revenue growth for Everest Medicines.Everest Medicines stated that it plans to build a multi-channel market access framework, provide diversified patient assistance programs and innovative payment solutions, and actively pursue the inclusion of VELSIPITY(R) in China’s National Reimbursement Drug List (NRDL) to improve the drug’s accessibility and affordability. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

越秀房产基金经营保持韧性 2025年收入逾人民币18亿元

香港, 2026年3月11日 - (亚太商讯 via SeaPRwire.com) - 越秀房地产投资信托基金( 〝越秀房产基金〞,连同越秀房托资产管理有限公司,统称〝基金〞;股份代号:405)公布其截至2025年12月31日止之全年业绩。越秀房产基金管理团队:主席及非执行董事江国雄先生(中)、执行董事及行政总裁区海晶女士(左)、财务总监关志辉先生(右)2025年全年业绩摘要:- 整体经营保持韧性,收入总额为人民币18.56亿元(2024年:人民币20.32亿元)。- 平均融资成本为3.61%,创近三年新低;平均付息率3.77%,同比下降76个基点,剔除汇兑亏损的融资成本同比减少约1.52亿元人民币。- 于2025年12月31日,物业整体出租率为82.1%(2024年同期:84.5%)。- 优化资产组合,于第四季度出售越秀金融大厦50%权益,回笼约人民币53亿元现金提升财务灵活度,获标普和惠誉维持〝投资级〞评级,并上调评级展望至〝稳定〞。- 末期分派每个基金单位约人民币0.0189元,约等于0.0214港元。全年度之每个基金单位分派约人民币0.0522元,约等于0.0580港元。按年计算的分派收益率为6.74%。- 为保持基金财务灵活性,于2025年7月1日至2025年12月31日期间的分派比率调整为90%,全年整体分派比率约为96%。广州国金中心:- 广州国金中心综合体录得经营收入为人民币9.84亿元,占基金收入总额53.0%。- 广州国金中心写字楼引进两家财富世界500强企业;出租率为80.9%。- 国金天地引进广州首家且目前唯一的市内免税店〝中免免税店〞,全年续租率89%,期末出租率95.5%。- 广州四季酒店平均房价同比提升5.8%,国金中心雅诗阁服务式公寓平均入住率达91.5%,同比增长1个百分点,营业收入创历史同期新高。积极管理融资风险,有效平抑融资成本- 针对2025年到期的人民币5.3亿元短期贷款、21亿港元5年期银团贷款以及38亿港元3年期银团贷款余下21亿港元,管理人于2025年完成人民币5.3亿元短期贷款续借,并通过取得17亿元人民币离岸贷款、发行10亿人民币点心债以及21亿港元等值境外银团组合贷款(为可持续发展挂钩贷款),用于到期贷款的再融资,确保流动性风险得到有效管控。- 年内合计引入人民币46.8亿元贷款,并部分置换境外浮息港元贷款,利用人民币融资相对低位,主动调节融资结构。2025年年末融资利率敞口约为10%,较年初26%收窄16个百分点;平均融资成本为3.61%,创近三年新低,较年初4.16%下降55个基点;2025年全年平均付息率3.77%,同比下降76个基点。剔除汇兑亏损的融资成本约为人民币7.73亿元,同比减少约人民币1.52亿元。- 2025年年末人民币融资约154.7 亿元,占总体融资76%(2024年:人民币融资约123.3 亿元,占总体融资60%)。越秀房产基金主席及非执行董事江国雄先生表示:〝2025年是越秀房产基金上市二十周年。管理人巩固优势,策略性抢占市场份额,以出租率为优先考虑,强化风险管控稳定续租,匹配市场需求增强产品竞争力,投入资本性改造确保资产保值增值,在充满挑战的市场中稳定经营基本面,为全年经营收入提供坚实支撑。与此同时,我们优化资产组合,适当降低写字楼业态占比,并敏锐捕捉有利融资窗口,先后成功发行全球首笔上市REITs‘熊猫债’及基金首笔绿债。全年融资成本创近三年新低,有效支撑整体分派水平。一系列开创性资本运作的成功实施,充分彰显管理人推动越秀房产基金高质量发展的战略目标,展现管理人为基金单位持有人创造可持续长远价值的坚定决心。〞国金中心国金中心年内新签15,702平方米。推出7,403平方米带装修单元,去化周期约36天,去化率接近72%。引进优质租户包括两家财富世界500强背景企业、一家财富中国500强企业、一家全球龙头航运企业和一家知名互联网背景文体娱乐企业,续租34,294平方米,续租率86%,留存优质租户包括六家财富世界500强企业和一家外国领事馆。国金中心入选观点〝表现力指数·2025商办资产运营表现〞TOP30榜单。国金天地完成主力租户〝广州友谊商店〞续租;引进广州首家且目前唯一的市内免税店〝中免免税店〞;落地负一层轻餐茶饮区、四楼和五楼餐饮业态品牌焕新,引进七家〝首店〞。会员运营成效显著,会员销售占比翻倍式提升至16%。积极打造电子化消费场景,充分利用主流平台多渠道引流。联动酒店、大剧院、博物馆、领事馆成功举办〝意大利文化季〞主题活动,有效促进客流与销售转化。新签和续租合计35,573平方米,续租率89%。出租率为95.5%。广州四季酒店年内首批改造客房年内入市,平均房价为人民币2,260元,同比提升5.8%,平均入住率为77.7%;每间可供出租客房收入(RevPAR)为人民币1,756元,同比增长0.9%;RevPAR竞争指数为110.0,在奢华酒店竞争群组中始终保持较领先的市场地位。国金中心雅诗阁服务式公寓期内平均入住率为91.5%,同比上升1个百分点;平均房价为人民币1,137元,同比提升1.6%;RevPAR为人民币1,040元,同比增长2.7%;RevPAR竞争指数达146.9,在高端公寓竞品市场中维持高位。公寓营业收入创历史同期新高,经营收入自2016年起连续十年稳居雅诗阁集团中国区第一名。越秀金融大厦管理人于第四季度出售越秀金融大厦50%权益。出售完成后,越秀金融大厦成为基金合资格少数权益物业。期末出租率为77.9%。白马大厦白马大厦引入广州、深圳和东莞核心产业集群优质客户,带动全年新签5,808平方米,一楼实现近五年首次满租,二楼出租率创近六年新高。年内组织22家原创品牌亮相日本东京时尚产业展、及中国国际服装服饰博览会等专业展会;开展〝白马时尚行 · 边贸供应链对接会〞,与新疆乌鲁木齐十家批发市场建立〝粤新服饰产业链供采合作联盟〞。全年累计接待517个采购团,累计接待采购商近1.3万人次,其中包括来自法国、越南等19个外商团,促成采购金额达人民币3.2亿元。期末出租率为96.0%。财富广场财富广场全年新签6,334平方米,成功引进多家优质租户,包括一家财富世界500强综合金融集团旗下多家企业、两家财富世界500强背景企业和两家全球行业龙头企业的广州分支机构。续租8,662平方米,续租率84.0%,包括三家财富世界500强背景企业和一家全国性商业银行广州分行。升级产品标准加快空置单元去化,带装修单元去化率达93%。期末出租率为93.4%,同比上升1个百分点,出租率较中期强劲回升5.4个百分点。城建大厦城建大厦年内新签9,279平方米,引进一家美容科技企业和一家医药供应链服务企业,提升楼内大健康业态氛围。续租5,011平方米,续租率77%,包括一家财富世界500强企业和一家全球知名合同研究组织(CRO)企业。期末出租率为90.6%。维多利广场维多利广场主力租户〝优衣库〞继续发挥旗舰作用,全年销售额同比增长7.0%,蝉联全国门店榜首。成功引进运动品牌〝超级安踏〞,打造广佛地区最大门店;成功引入贵州香辣蟹全国首店〝蟹莽莽〞,丰富餐饮品牌组合。联动内外部资源举办十五场大型活动,实现商场全年销售额同比增长2.0%。全年新签和续租合计5,579平方米,续租率84%。期末出租率为94.0%。上海越秀大厦上海越秀大厦全年续租6,430平方米,续租率43%;新签8,070平方米,有效填补退租单元。持续匹配市场需求增加小面积带装修单元供应,制定差异化定价策略,成功举办渠道招商会,吸引百家中介机构参与,并投入多项资本性改造推动节能效益和服务水平持续提升。期末出租率为83.1%。武汉物业武汉越秀财富中心年内新签26,837平方米,引进优质租户包括两家财富世界500强背景央企和两家财富世界500强背景外资企业。续租20,617平方米,续租率76.0%创近三年新高,留存优质租户包括七家财富世界500强背景企业和一家财富中国500强背景企业。全年改造单元供应约2.1万平方米,去化率接近98%。期末出租率为62.1%,同比上升1个百分点。武汉星汇维港购物中心年内焕新多家热门餐饮和健身品牌,吸引更多家庭和年轻客群,依托〝悦花园〞场地特色深度挖掘〝夜经济〞与〝场景体验〞消费潜力,举办〝江畔星夜〞主题活动,实现客流量同比基本持平,商场年度销售额同比提升0.5%。全年新签和续租合计9,827平方米,续租率48.0%。期末出租率为87.4%,较中期回升5.0个百分点。杭州维多利杭州维多利全年新签7,890平方米,引进一家全层租户。续租8,836平方米,续租率54%,留存优质租户包括两家财富世界500强背景企业和一家山西省属国企的浙江分公司。期末出租率为84.5%。ESG融合业务,推进可持续发展管理人秉承长期主义理念,系统布局ESG工作,值此连续第十年对外披露越秀房产基金可持续发展实践之际,管理人正式将〝环境、社会及管治报告〞更名为〝可持续发展报告〞,以此进一步促进越秀房产基金战略与可持续发展深度融合、同频共进。年内,首次荣获全球房地产可持续发展基准(GRESB)最高绿色五星评级及〝全球行业领导者〞称号,公开披露再次获最高〝A〞级等,彰显了在可持续发展领域的卓越实力。未来展望未来一年,管理人将保持审慎乐观的态度,〝以变应变〞强化风险管理,致力为基金单位持有人创造稳定回报。资产管理方面,将因应经济发展走势和竞争环境演变,动态实施积极、稳健、灵活的租赁和营运策略,发掘新增长点、把握潜在机会提升资产组合市场竞争力。融资管理方面,将持续对融资结构进行合理调整,通过各类融资途径引入低成本人民币融资,平滑利率风险。工程改造方面,将有序分段改造广州四季酒店,护航物业长效保值增值。关于越秀房地产投资信托基金越秀房地产投资信托基金(〝越秀房产基金〞)于2005年12月21日在香港联交所上市,为全球首只投资于中国内地物业的上市房地产投资信托基金。截至2025年12月31日,越秀房产基金之物业组合共有十项(包括一项合资格少数权益物业),分别位于广州的白马大厦、财富广场、城建大厦、维多利广场、广州国际金融中心、越秀金融大厦(合资格少数权益物业,实益权益49.495%)、位于上海的越秀大厦、位于武汉的武汉越秀财富中心、星汇维港购物中心、位于杭州的维多利商务中心及位于香港的越秀大厦。不包括越秀金融大厦,物业总建筑面积约为97.4万平方米,分别位于中国广州市、上海市、武汉市、杭州市及香港市的核心商业区域。物业类型包括甲级写字楼、商业综合体、零售商业、酒店、服务式公寓、服装专业市场等。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

MarketingPulse and eTailingPulse open next Thursday

HONG KONG, Mar 11, 2026 - (ACN Newswire via SeaPRwire.com) – Organised by the Hong Kong Trade Development Council (HKTDC), MarketingPulse and eTailingPulse – Asia’s premier annual e-commerce and marketing events – will be held concurrently on 19 March at the Hong Kong Convention and Exhibition Centre (HKCEC). Under the theme "Generate New Growth", this year's conferences focus on how brands can rethink their growth strategies amid global market uncertainty, helping to turn challenges into forward momentum. From strategic insights to practical implementation, the events will comprehensively reveal new directions for growth, bringing together about 70 global e-commerce experts, marketing executives, brand representatives and advertising elites to share valuable insights and success stories relating to global marketing and e-commerce trends. Featuring 30 thematic sessions, seminars and demonstration sessions, the events will help to foster cross-sector exchange and boost collaboration within the industry.The rise of e-commerce has injected new momentum into global economic growth, while the government is actively encouraging small and medium-size enterprises (SMEs) to develop e-commerce capabilities that can enhance their market competitiveness. This year’s conferences will focus on the latest developments in e-commerce, helping participants seize growth opportunities in the current market environment through a dual-track approach that advances both e-commerce development and brand marketing. A lineup of experts will speak on topics such as agentic AI, lifestyle e-commerce, quick commerce and global brand expansion. They will examine innovation in e-commerce along with global marketing trends and emerging consumer opportunities, while exploring how the industry can generate new growth amid a rapidly evolving marketing landscape.Tech marketing expert shares insights on data-driven growthJinhee Lee, Chief Operating Officer of Olive Young, South Korea’s leading health and beauty brand, will present on the theme “Beyond Retail, Building an Ecosystem: Driving Collaborative Growth of Olive Young and K-Beauty”. Drawing on perspectives from both marketing and e-commerce, he will explain how seamless omnichannel operations and data-driven marketing strategies are being leveraged to build a high-growth ecosystem for Korean beauty brands, while continuously expanding their global footprint. Well-known for harnessing data to drive innovation, Mr Lee has spearheaded a series of digital transformation initiatives and integrated retail strategies, using technology to enable Olive Young to stay ahead of trends and become a leader in the global beauty market.Breaking new ground in marketing through the China experience and new retailAtour Group is a leading player in Chinese Mainland’s mid- to high-end hotel chain market. Its Founder, CEO & Chief Experience Officer, Haijun Wang, will focus on two key themes during his presentation: 1) Experience Differentiation Strategy — placing differentiated experiences at the core to build distinctive product and service offerings across both the hotel and retail businesses; and 2) Customer Segment Operations Strategy — using a core customer base that pursues a quality lifestyle as the connective thread to deeply integrate the hotel and retail businesses, thereby shaping a unique brand group model.Enhancing brand value through aesthetic intelligence in e-commercePauline Brown, former Chairman of LVMH North America, will share how to leverage "aesthetic intelligence" to elevate brand value, shape consumer perception and strengthen overall online-to-offline experiences and marketing strategies. She will also discuss how brands can continuously cultivate "taste" and aesthetic acumen and explain how aesthetics and elevated storytelling can be utilised to build truly compelling brands in a rapidly changing e-commerce and technological landscape.Exploring the latest trends in agentic AI and quick commerceQuick commerce and agentic AI are bringing unprecedented changes to the e-commerce market in the Chinese Mainland, continuously reshaping consumers' shopping patterns, habits and demands. Yatong Qiu, Vice President of Taobao&Tmall Group, Alibaba, will share on how brands and merchants can tackle demand through flexible merchandising strategies, real-time marketing and speed-oriented innovations to maintain competitiveness and seize time-sensitive opportunities. Meanwhile, Terry Li, Vertical General Manager of Smart Retail, Tencent, will take a deeper dive into agentic AI-driven e-commerce strategies. Looking from the perspectives of service providers and e-commerce ecosystems, he will share practical approaches and future innovation directions for agentic AI solutions, helping brands and businesses seize the initiative in the new era of e-commerce.Decoding cross-border growth and market entry strategies for ASEANAs ASEAN continues to rise as one of the world's most dynamic economic regions, enterprises from the Chinese Mainland and Hong Kong are actively setting their sights on Southeast Asia, particularly seeking growth opportunities through e-commerce channels. The conferences will feature a session titled “Decoding the Gateway to ASEAN: Cross Border Growth and Market Entry Strategies”, exploring strategies for entering the ASEAN market. Speakers including Luca Barni, SVP, Commercial, Lazada Group, will share their practical experiences in expanding within ASEAN. Attendees will get a comprehensive understanding of the growth opportunities and common pitfalls in this growing market, addressing e-commerce legal and regulatory challenges, as well as brand and product localisation strategies.Cracking the Threads audience engagement plus celebrity insightsThe recent rise of social platform Threads is further driving the evolution of brand marketing models. In the "Threads for Consumer and Audience Engagement" session, Kenie Kwok, Creative Strategy Lead at Meta, will share the latest trends in brand account management and user preferences from the platform's perspective. Actor and "Threads Admin" Ng Siu-hin will share his insights on how to stand out as a content creator, offering practical tips on building engagement with netizens from a creator's viewpoint. In addition, IN.DECIDE, renowned for managing social media platforms for multiple brands as an "admin", will analyse its promotional campaign for the film Peg O' My Heart, detailing how the virtual character "Choi San-keung" successfully broke the fourth wall with the audience.This year's "Meet the Celebrity” dialogue series has invited actor and singer-songwriter Louis Cheung to speak on the topic "Chasing the Golden Boy Within". He will share his career journey in personal brand management and talk about his multifaceted development across the acting, music and creative fields. Meanwhile, content creator and MUSE TV Founder Mayao will discuss how he strategically leverages innovative promotional approaches to market music works, generating broad and lasting public impact and driving sustainable market growth.Exploring the “healing economy" and IP marketingWhen engaging with younger generations, who place strong emphasis on emotional connection, brands must understand “oshikatsu culture”, where young people identify strongly as a fan of an idol, along with the healing trend and intellectual property (IP)-driven consumer behaviour. The session "Healing Economy and IP Marketing" will feature speakers including Yiying Wang, Founder and Designer of Noodoll Limited, who will explore how brands can keep abreast of the latest trends, such as designing sustainably interactive experiences and campaigns with an "oshikatsu mindset", incorporating healing elements into products or marketing to enhance resonance, and collaborating with popular IPs to boost reach and engagement, thereby deepening connections and relationships with younger demographics.The conferences will introduce a new feature, "e-Commerce Connect", showcasing the latest one-stop e-commerce solutions, with close to 30 local and international exhibitors. Additionally, a series of digital marketing and e-commerce workshops will enable participating brands to gain hands-on practical experience. Multiple networking activities will be organised, and participants can take advantage of one-to-one business matching services to facilitate cross-sector exchange and collaboration. The event will also feature live music performances, including a set from popular local singer James Ng.For more information on speakers and the detailed programme for the conferences, please visit: https://marketingpulse.hktdc.com/conference/mp/en. To request interviews with guest speakers, please email betsytse@raconteur.hk or molisalau@raconteur.hk.Photo download: https://bit.ly/3OU0UArPauline Brown, Former Chairman of LVMH North AmericaHaijun Wang, Founder and CEO of Atour Lifestyle HoldingsJinHee Lee, Chief Operating Officer of Olive YoungLouis Cheung, Actor and singer-songwriterNg Siu-hin, Artist and "Threads Admin"MarketingPulse and eTailingPulse will be held on 19 March at the Hong Kong Convention and Exhibition Centre. Pictured are the MarketingPulse and eTailingPulse events held in 2025Websites· MarketingPulse: https://marketingpulse.hktdc.com/conference/mp/en· Event schedule: https://marketingpulse.hktdc.com/conference/mp/en/programme· Speaker list: https://marketingpulse.hktdc.com/conference/mp/en/speaker· eTailingPulse: https://etailingpulse.hktdc.com/conference/etp/en· EntertainmentPulse: https://hkfilmart.hktdc.com/conference/hkfilmart/en Media enquiriesFor enquiries, please contact:Raconteur PR Agency:Betsy TseTel: (852) 9742 7338Email: betsytse@raconteur.hkMolisa LauTel: (852) 6187 7786Email: molisalau@raconteur.hkHKTDC Communication and Public Affairs Department:Clayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

ShelterZoom推出Document GPS®安全框架以应对人工智能驱动的网络攻击

(SeaPRwire) -   佛罗里达州迈阿密——2026年11月3日——(SeaPRwire)——随着人工智能重塑网络安全格局,安全研究人员正观察到网络攻击执行方式的转变。许多现代攻击不再仅仅依赖传统恶意软件或软件漏洞,而是越来越多地依靠使用真实组织数据训练AI系统。当合同、发票、内部通信和运营文件等文档被无意中分享到企业环境之外或上传到未授权的AI工具时,它们可能成为攻击者宝贵的训练材料。 针对这种新兴威胁模式,科技公司ShelterZoom推出了一种安全架构,旨在防止敏感文档成为可被利用的数据源。该公司的Document GPS®平台旨在消除文档内容的暴露,并建立其所谓的针对影子AI使用和AI驱动社会工程的结构性防御机制。 据ShelterZoom介绍,该方法的重点是防止敏感文件以AI系统可分析或复用的形式离开组织。通过阻止底层数据流,该平台旨在中断使AI驱动攻击变得越来越精确和具有说服力的反馈循环。 “AI不一定需要入侵系统才能变得危险——它只需从真实文档中学习即可,”ShelterZoom首席执行官兼联合创始人Chao Cheng-Shorland表示。“一旦真实文件离开公司,它们就可能成为 impersonation(模仿)和 manipulation(操纵)的训练材料。我们Document GPS的目标是消除这种暴露。” 为文档安全引入新的数字层 ShelterZoom系统的核心是其专利和商标技术Document Token®。这种数字机制将所有权、安全策略和跟踪功能直接嵌入到单个文件中。 在区块链技术的支持下,Document Token使文档即使在离开内部网络后也能保持防篡改、可追溯性和可执行控制。该公司将此描述为将传统文档转变为具有内置治理的便携式数字资产。 正如现代软件架构将应用程序转变为可在分布式环境中运行的便携式组件一样,Document Token旨在将普通文件转换为受控数字单元,无论在何处访问都保持可识别、可跟踪和安全。 应对影子AI日益增长的风险 影子AI——定义为员工未经授权使用人工智能工具——已成为组织日益关注的问题。在许多情况下,员工可能会将机密材料上传到外部AI平台以加快工作任务,而没有充分考虑安全影响。 ShelterZoom表示,其平台旨在在电子邮件通信、基于网络的工作流程和移动文件共享等常见暴露点解决此问题。Document GPS不发送原始形式的文档,而是将出站文件转换为由加密和基于区块链的控制管理的标记化资产。系统内的私人消息默认也会加密。 在此模型下,文档本身不会以允许AI系统收集或分析的方式物理传输。因此,敏感信息无法被收集或重新用作AI辅助攻击的训练材料。 “如果AI系统无法访问底层文档内容,它们就没有有意义的东西可学习,”Cheng-Shorland解释道。“这大大降低了模仿尝试和AI生成操纵的有效性。” 为什么传统安全措施难以应对 许多现有的网络安全策略强调检测——识别恶意电子邮件、可疑链接或异常用户行为。然而,一旦员工自愿(即使是不知情地)分享敏感文件,这些保护措施就可能失去效力。 ShelterZoom认为,这一差距为依赖AI工具分析泄露信息并生成高度逼真的网络钓鱼或模仿尝试的攻击者创造了机会。 通过防止文档以可读形式离开受控环境,Document GPS系统旨在打破为AI增强型网络攻击提供动力的数据学习循环。没有真实材料可供分析,攻击者复制可信身份或创建令人信服的欺诈性通信将面临更大困难。 这种方法反映了网络安全思维的更广泛转变——从保护网络边界转向保护数据本身,无论数据流向何处。 降低AI辅助攻击的动机 该平台的另一个目标是降低针对组织的经济吸引力。当攻击者无法获取真实文档或通信背景时,AI驱动的活动将变得不那么精确和成功。 没有可靠的数据源,攻击者必须依赖通用的网络钓鱼策略,而这些策略历史上成功率较低。 ShelterZoom认为,这种转变可以使采用文档级保护系统的组织与数据仍可通过传统工作流程访问的公司相比,成为不那么有吸引力的目标。 关于ShelterZoom ShelterZoom是一家总部位于佛罗里达州迈阿密的深度科技公司,专注于网络安全、数字内容所有权和数据完整性解决方案。该公司已开发出近80项专利和商标组合,涵盖文档控制、基于区块链的验证和数据保护相关技术。 2022年至2024年连续三年被Gartner®评为市场领导者,ShelterZoom继续专注于推进旨在增强数字弹性的解决方案。其创新包括Document Token技术、Single Source of Truth® (SSOT)架构、针对医疗电子健康记录停机的Spare Tire解决方案,以及旨在减轻AI幻觉、数据不准确和数据泄露相关风险的工具。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD(TM) 2026 Annual Meeting

TOKYO, Mar 11, 2026 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today the company will present the latest findings on lecanemab (generic name, U.S. brand name: LEQEMBI®), Eisai’s anti-amyloid beta (Aβ) protofibril antibody for the treatment of Alzheimer’s disease (AD), at the 20th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD™ 2026) from March 17-21, in Copenhagen, Denmark, and online. The lecanemab data and additional research findings from Eisai’s AD portfolio will be featured in six presentations, including three oral presentations. Eisai will host an industry-sponsored symposium.Oral and Poster PresentationsOral presentations will include the latest findings from a United States real-world long-term treatment persistence study, and efficacy and safety outcomes in apolipoprotein E ε4 (ApoEε4) homozygous carriers in a U.S. multicenter real-world study. In addition, four-year data from the Clarity AD Open-Label Extension trial in ApoEε4 non-carriers and heterozygotes, and a genome-wide association study on novel genetic variants associated with cognitive decline in AD will be presented as posters.Eisai Symposium – Continue Life Their Way: Early Intervention in Alzheimer’s DiseaseEisai is sponsoring a symposium featuring four leading global experts in the field of AD, on the topics of why early intervention matters, continuing early AD treatment and real-world outcomes. The symposium aims to enhance understanding of the value of early and continued anti-amyloid treatment in early AD by exploring how real-world evidence can support confident patient assessment in clinical practice, and how to recognize AD as a chronic condition that requires a multidisciplinary approach to care.Eisai serves as the lead of lecanemab development and regulatory submissions globally with both Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making authority.AD/PD 2026 Presentations Relating to Eisai's Key Compounds and ResearchFor more information, please visit: https://www.eisai.com/news/2026/pdf/enews202612pdf.pdfMedia Inquiries:Public Relations Department,Eisai Co., Ltd.+81-(0)3-3817-5120Eisai Europe, Ltd.(Europe, Australia, New Zealand and Russia)EMEA Communications Department+44 (0) 7739-600-678EMEA-comms@eisai.netEisai, Inc. (U.S.)Julie Edelman+1-862-213-5915Julie Edelman@eisai.comAbout Lecanemab (generic name, brand name: Leqembi)Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ).Lecanemab has been approved in 53 countries and regions including Japan, the United States, China, Europe, South Korea, Taiwan, and Saudi Arabia, and is under regulatory review in 6 countries. Following the initial phase with treatment every two weeks for 18 months, intravenous (IV) maintenance dosing with treatment every four weeks was approved in 7 countries including the U.S., China, the UK, and others, and applications have been filed in 10 countries and regions. The U.S. FDA approved Eisai’s Biologics License Application (BLA) for subcutaneous maintenance dosing with LEQEMBI IQLIK in August 2025. A Supplemental Biologics License Application (sBLA) for initiation treatment was accepted in January 2026. The sBLA has been granted Priority Review, with a Prescription Drug User Fee Act (PDUFA) action date of May 24, 2026. In November 2025, an application for a subcutaneous injectable formulation in Japan was submitted. In January 2026, the Biologics License Application (BLA) for the subcutaneous formulation was accepted in China. In December 2025, Lecanemab (IV) has been included in the “Commercial Insurance Innovative Drug List”, recently introduced by the National Healthcare Security Administration (NHSA) of China.Since July 2020 the Phase 3 clinical study (AHEAD 3-45) for individuals with preclinical AD, meaning they are clinically normal and have intermediate or elevated levels of amyloid in their brains, is ongoing. AHEAD 3-45 is conducted as a public-private partnership between the Alzheimer's Clinical Trial Consortium that provides the infrastructure for academic clinical trials in AD and related dementias in the U.S, funded by the National Institute on Aging, part of the National Institutes of Health, Eisai and Biogen. Since January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy.About ProtofibrilsProtofibrils are believed to contribute to the brain injury that occurs with AD and are considered to be the most toxic form of soluble Aβ, having a primary role in the cognitive decline associated with this progressive, debilitating condition.¹ Protofibrils cause injury to neurons in the brain, which in turn, can negatively impact cognitive function via multiple mechanisms, not only increasing the development of insoluble Aβ plaques but also increasing direct damage to brain cell membranes and the connections that transmit signals between nerve cells or nerve cells and other cells. It is believed the reduction of protofibrils may prevent the progression of AD by reducing damage to neurons in the brain and cognitive dysfunction.²About the Collaboration between Eisai and Biogen for ADEisai and Biogen have been collaborating on the joint development and commercialization of AD treatments since 2014. Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with both companies cocommercializing and co-promoting the product and Eisai having final decision-making authority.About the Collaboration between Eisai and BioArctic for ADSince 2005, Eisai and BioArctic have had a long-term collaboration regarding the development and commercialization of AD treatments. Eisai obtained the global rights to study, develop, manufacture and market lecanemab for the treatment of AD pursuant to an agreement with BioArctic in December 2007. The development and commercialization agreement on the antibody lecanemab back-up was signed in May 2015.References1. Amin L, Harris DA. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat Commun. 2021;12: 3451. doi:10.1038/s41467-021-23507-z.2. Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

真主党和伊朗协同对以色列发动集束炸弹袭击,局势大幅升级

(SeaPRwire) -   一位国家安全专家称,真主党和伊朗周二发起了一项协同打击战略,此前有报道称致命的集束弹药正在以同步攻击的方式袭击以色列。这些事态发展发生在“史诗之怒”和“怒吼雄狮”行动的第11天,这是美国和以色列针对伊朗的联合行动,标志着日益扩大的地区冲突可能升级。国家安全研究所和米斯加夫研究所的高级研究员科比·迈克尔(Kobi Michael)在特拉维夫附近的防空洞中对 Digital 表示:“真主党已全面参战,看起来他们现在与伊朗的协调非常良好。”他说:“真主党的大部分火箭和无人机都是与伊朗导弹同时发射的。”据美联社报道,以色列周二证实伊朗一直在发射集束弹药——这给以色列捉襟见肘的防空系统带来了复杂而致命的挑战。弹头在高空爆裂,将数十枚小型子弹药散布到广阔区域。这些小型炸弹在夜间可能像橙色火球,难以拦截,并已被证明具有致命性。记者内特·福伊(Nate Foy)也表示,尽管以色列拥有强大的防空系统,但一半的导弹难以防御,因为其中一半是集束弹药。迈克尔敦促道:“伊朗使用集束导弹以及他们蓄意瞄准平民和民用设施的行为,必须被视为使用非常规武器,美国和以色列的反应必须是适当的。”这些武器在2008年《集束弹药公约》下被120多个国家禁用,因其广域、不分青红皂白的效应而受到广泛谴责,这些效应常常导致灾难性的平民伤害。迈克尔发表此番言论之际,路透社报道称,真主党正在吸取其上次与以色列战争的教训,为可能发生的以色列全面入侵和长期冲突做准备。 报道称,消息人士声称该组织正在回归其在黎巴嫩南部的游击战根源。熟悉真主党军事活动的消息人士称:“这个受伊朗支持的组织的武装分子以小股部队行动,避免使用可能面临以色列窃听风险的通信设备,并在与以色列军队交战时定量使用关键的反坦克火箭。”迈克尔还表示,“该国北部,海法地区方向,正遭受猛烈轰炸。”他说:“以色列公民不得不大部分时间待在防空洞里,因为真主党和伊朗蓄意瞄准平民和民用设施。”他补充说:“特拉维夫仍处于紧急状态,警报持续不断,许多人长时间待在防空洞里。”随后他强调,“以色列是一个小国,无法继续容忍这种不对称和这种消耗战。”截至当地时间周二晚,以色列国防军表示已对贝鲁特南部郊区的真主党基础设施发动了一波空袭。 此前,军方重申了撤离该地区的警告,该地区是真主党的一个据点,被称为达希耶(Dahiyeh)。以色列国防军在X上分享的一篇帖子中说:“这就是我们正在打击的目标。”路透社消息人士还称,真主党的大部分地面战斗迄今集中在基亚姆镇附近,该镇位于黎巴嫩与以色列和叙利亚边境的交界处。这是真主党认为以色列任何地面入侵都可能开始的区域之一。报道称,真主党的精锐部队拉德万(Radwan)战士在2024年停火后从南部撤出,也已返回该地区。迈克尔说:“以色列无疑将控制黎巴嫩南部从国际边界到利塔尼河的广大地区,以建立一个安全缓冲区。”迈克尔补充说:“这将阻止真主党袭击该国北部的以色列村庄和城镇,并将加剧对黎巴嫩各地真主党的袭击。”“我们希望特朗普总统不会停止,也不会使用他对待胡塞武装的策略,即宣布胜利并让受伤的狮子无法复仇和/或重组。”与此同时,一名不愿透露姓名的以色列军方官员周二表示,伊朗向以色列发射的弹药中约有一半现在是集束炸弹,美联社报道。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

iTrustCapital推出加密货币财库账户,助力企业实现资产负债表多元化

(SeaPRwire) -   加利福尼亚州欧文市 – 2026年3月11日 – (SeaPRwire) – 随着数字资产日益成为现代金融策略中引人注目的组成部分,越来越多的机构正探索将加密货币及另类资产纳入其资金管理框架的方法。为响应这一趋势,金融科技平台iTrustCapital宣布推出其金库账户(Treasury Account),这一全新服务旨在帮助企业、信托及非营利组织安全管理数字资产,将其作为资产负债表策略的一部分。 加密货币金库账户(Crypto Treasury Account)推出了机构级解决方案,允许包括公司、有限责任公司(LLC)、S型公司(S-Corporations)、合伙企业、信托及非营利组织在内的机构,在安全的基础设施内买卖和持有加密货币及贵金属。该产品扩展了iTrustCapital现有平台功能,基于此前为个人投资者开发的高级托管账户(Premium Custody Account, PCA)进一步升级。 企业资金管理方式的演变 数十年来,许多机构严重依赖现金储备作为主要资金资产。然而,长期的通胀压力及不断变化的经济环境,促使企业重新审视持有大量闲置现金的长期价值。 随着各司法管辖区围绕数字资产的监管透明度持续提升,加密货币已逐渐融入更广泛的资产多元化讨论。尽管早期采用主要由零售投资者推动,但机构参与者及企业实体正越来越多地评估比特币(Bitcoin)、以太坊(Ethereum)等数字资产作为潜在资金持有标的的可能性。 多家上市公司已将加密货币纳入其资金投资组合,这反映了数字资产融入企业财务策略的更广泛趋势。 私有金融科技公司iTrustCapital表示,其早年便开始将数字资产配置到自身资金中,作为长期财务规划的一部分。据该公司称,管理这些资产的经验为其新推出的加密货币金库账户提供了开发依据。 iTrustCapital首席执行官凯文·马洛尼(Kevin Maloney)表示,该新产品旨在帮助机构实现资金管理实践的现代化。在他看来,维持闲置现金储备可能随时间削弱购买力,促使企业寻求更多资本保值与多元化策略。 金库账户的核心功能 新推出的金库账户包含多项旨在支持机构级安全、可访问性及资产管理的功能。 7×24小时访问数字资产和贵金属 客户可通过平台买卖和持有超过85种加密货币,包括比特币(BTC)、以太坊(ETH)、瑞波币(XRP)及索拉纳(SOL)等主要资产。该账户还允许机构在同一平台环境下交易实物黄金和白银。 闭环安全架构 系统在旨在增强资产保护的闭环基础设施内运行。美元存款仅接受来自客户美国银行账户的资金,加密货币存款可直接转入。提现将以美元形式转回原银行账户。 1:1资产托管模式 客户资产与美国第三方银行机构及托管方以1:1比例保管。据该公司称,这些资产不被用于杠杆操作,也不与运营资金混合。 加密货币质押机会 平台当前支持以太坊(ETH)和索拉纳(SOL)的质押,允许客户在持有这些资产时获得奖励。未来可能推出更多质押选项。 专属客户支持 iTrustCapital提供美国本地实时客户支持,协助机构完成账户设置、资金流程及日常交易。该公司指出,其服务团队在Google、Trustpilot等平台上获得了超过13,000条客户正面评价。 依托不断增长的平台基础 自2018年成立以来,iTrustCapital已定位为专注于通过税收优惠及自主管理账户提供另类资产访问的金融科技平台。该公司称,其平台已创建超过30万个账户,产生了逾160亿美元的交易量。 加密货币金库账户的推出是该公司的最新扩展举措,将服务范围从个人投资者延伸至寻求结构化数字资产管理解决方案的企业、信托及非营利实体。 有意了解金库账户更多信息的机构,可访问iTrustCapital官网或直接联系该公司获取详情。 关于iTrustCapital iTrustCapital是一家专注于另类资产投资的金融科技软件平台。该公司通过自主管理个人退休账户(IRA)及非IRA账户选项,提供对数字资产、加密货币及贵金属的持续访问。 平台通过由美国第三方银行及托管方支持的闭环生态系统运行,旨在为零售及机构用户提供更高的安全性与灵活性。 iTrustCapital在美国或其他司法管辖区并非交易所、托管方、经纪商、投资顾问或持牌金融中介机构。 数字资产属于高风险投资,可能存在损失风险。iTrustCapital不提供法律、税务或投资建议。鼓励个人及机构在做出投资决策前咨询合格的法律、税务或金融专业人士。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。

JOYY Reports 4Q and FY2025 Financial Results: Q4 Revenue Returns to YoY Growth, BIGO Ads Up 61.5% YoY

SINGAPORE, Mar 11, 2026 - (ACN Newswire via SeaPRwire.com) – JOYY Inc. (NASDAQ: JOYY) announced its unaudited financial results for the fourth quarter and full year of 2025.In the fourth quarter of 2025, JOYY’s total revenue was US$581.9 million, up 7.7% quarter over quarter and 5.9% year over year, marking a return to year-over-year revenue growth. Livestreaming revenue was US$394.4 million, up 1.5% quarter over quarter, marking the third consecutive quarter of sequential growth. BIGO Ads delivered accelerating revenue growth, up 61.5% year over year to US$128.1 million. For the full year of 2025, total revenue was US$2.12 billion. Livestreaming contributed US$1.53 billion, while BIGO Ads contributed US$398.5 million, up 38.5% year over year, driving total non-livestreaming revenue, including ad revenue and others, to 28.0% of the Company’s revenue, up 7.9 percentage points from 2024.In 2025, JOYY delivered steady profitability growth. Non-GAAP[1] operating income and non-GAAP[1] EBITDA were US$150.8 million and US$189.8 million, up 10.8% and 10.9% year over year, respectively. In the fourth quarter, non-GAAP1 operating income stood at US$40.8 million, and operating cash flow for the fourth quarter totaled US$116.0 million. As of December 31, 2025, the Company held US$3.26 billion in net cash.JOYY previously announced a shareholder return program of approximately US$900 million through dividends and share repurchases from 2025 through 2027. The Company has been actively executing its share repurchase program, with repurchases totaling US$67.4 million in the fourth quarter. In total, JOYY has distributed approximately US$332.0 million in dividends and share repurchases throughout 2025. In light of the double-digit improvements in operational profit in 2025, the Company will distribute an additional cash dividend of approximately US$20 million in the first quarter of 2026.Fourth Quarter 2025 Financial Highlights- Net revenues increased by 5.9% to US$581.9 million from US$549.4 million in the corresponding period of 2024 and by 7.7% from US$540.2 million in the third quarter of 2025.Livestreaming revenue was US$394.4 million, representing an increase of 1.5% from US$388.5 million in the third quarter of 2025.Advertising revenue increased by 62.4% to US$145.4 million from US$89.6 million in the corresponding period of 2024 and by 29.3% from US$112.5 million in the third quarter of 2025.Other revenues increased by 12.3% to US$42.1 million from US$37.5 million in the corresponding period of 2024 and by 7.2% from US$39.2 million in the third quarter of 2025.- Operating income was US$18.3 million.- Non-GAAP1 operating income was US$40.8 million.- Net Cash as of December 31, 2025 was US$3.26 billion.- Net cash from operating activities was US$116.0 million, compared with US$110.5 million in the corresponding period of 2024.Full Year 2025 Financial Highlights- Net revenues were US$2,124.2 million.- Operating income was US$55.8 million.- Non-GAAP1 operating income was US$150.8 million, up 10.8% from US$136.1 million in 2024.- Non-GAAP1 EBITDA was US$189.8 million, up 10.9% from US$171.2 million in 2024.[1]This press release includes certain non-GAAP financial measures as additional clarifying items to aid investors in further understanding the Company's performance and the impact that these items and events had on the financial results. The non-GAAP financial measures provided above should not be considered as a substitute for, or superior to, the measures of financial performance prepared in accordance with GAAP. For details of the non-GAAP measures, including the reconciliations of GAAP measures to non-GAAP measures, please refer to the press release titled “JOYY Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results” issued by the Company on March 11, 2026. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

致命精锐‘黑衣’杀戮小队护卫伊朗新最高领袖穆贾塔巴·哈梅内伊

(SeaPRwire) -   数字媒体获悉,在伊朗最高领袖阿亚图拉·阿里·哈梅内伊遇刺身亡后,一支精锐反恐部队被部署来保护伊朗新任命的最高领袖穆贾塔巴·哈梅内伊。这支被称为NOPO——伊朗黑衣反恐特种部队——的部队在2月28日美以对德黑兰一处建筑群发动袭击导致哈梅内伊长老身亡,且“史诗愤怒行动”开始之际,被指派来护卫最高领袖。总部位于巴黎的伊朗全国抵抗委员会外事委员会官员阿里·萨法维表示:“随着哈梅内伊离世,NOPO现在将保护穆贾塔巴·哈梅内伊。”萨法维称,这支成立于1991年的部队最初是伊朗伊斯兰革命卫队第28鲁霍拉(霍梅尼的名)师的“核心”,通常负责人质救援行动。该部队的历史还包括应对内部安全威胁的部署,且常被调用来镇压抗议活动。伊朗专家会议于2026年3月8日选举穆贾塔巴·哈梅内伊为伊朗伊斯兰共和国的第三任最高领袖。他的继任正值与美国和以色列的持续战争期间,但到目前为止,自冲突开始以来还没有穆贾塔巴·哈梅内伊的消息。据《以色列时报》报道,伊朗国家电视台称穆贾塔巴·哈梅内伊在战争中受伤,但这些报道尚未得到证实。萨法维进一步解释说:“NOPO是波斯语Nirouyeh Vijeh Pasdaran Velayat的缩写,意为‘保护最高领袖特种部队’。”随着时间推移,NOPO已发展成为一个与范围更广的伊朗伊斯兰革命卫队(IRGC)不同的高度专业化部队,伊朗伊斯兰革命卫队成立于1979年,旨在保卫伊斯兰共和国及其领导层免受内外威胁。萨法维说:“NOPO仅由六个旅组成。四个驻扎在德黑兰,一个在马什哈德,一个在伊斯法罕。”“他们比伊斯兰革命卫队更致命、更冷酷且训练有素,”他声称,然后描述了该旅的忠诚仅指向最高领袖。萨法维接着说:“这支部队仅用于保护哈梅内伊。他们装备精良。哈梅内伊不信任其他任何安全部队来保护自己。”萨法维还表示,该部队的一些成员在阿里·哈梅内伊遇刺时丧生,但该部队仍全面运作。萨法维说:“哈梅内伊遇刺时,一些NOPO成员丧生,但事实是,他们现在参与了政权最近几天采取的镇压和安全措施,以防止任何抗议活动爆发。”萨法维补充说,这支精锐部队在危机时期的活动不仅限于个人保护。“但在危机时期,比如1月份的起义期间,他们大量参与向抗议者开火,”他说。与此同时,有报道称,数百名NOPO成员也被广泛部署在伊朗关押政治犯的监狱周围。“监狱周围广泛部署了数百名镇压力量。在盖泽尔哈萨尔监狱,”伊朗全国抵抗委员会在一份声明中说。2026年3月3日星期二,在马哈巴德监狱附近的一个军事中心遭到轰炸后,病房门被锁住的囚犯进行抗议,并点燃毯子,要求在战时条件下获释。伊朗全国抵抗委员会报道:“镇压力量向病房发射催泪瓦斯回应。”报道还指出,在冲突加剧期间,常规监狱官员逃离后,NOPO控制了德黑兰的埃文监狱。2021年,美国财政部因NOPO参与“对伊朗人、伊朗公民或居民或其家属实施严重侵犯人权行为”而对其实施制裁。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。